CISPLATIN INJECTION BP SOLUTION

البلد: كندا

اللغة: الإنجليزية

المصدر: Health Canada

اشتر الآن

تأكيد الحساب خصائص المنتج (SPC)
29-09-2020

العنصر النشط:

CISPLATIN

متاح من:

SANDOZ CANADA INCORPORATED

ATC رمز:

L01XA01

INN (الاسم الدولي):

CISPLATIN

جرعة:

1MG

الشكل الصيدلاني:

SOLUTION

تركيب:

CISPLATIN 1MG

طريقة التعاطي:

INTRAVENOUS

الوحدات في الحزمة:

10/50/100ML

نوع الوصفة الطبية :

Prescription

المجال العلاجي:

ANTINEOPLASTIC AGENTS

ملخص المنتج:

Active ingredient group (AIG) number: 0113245002; AHFS:

الوضع إذن:

CANCELLED POST MARKET

تاريخ الترخيص:

2022-07-25

خصائص المنتج

                                PRODUCT MONOGRAPH
PR
CISPLATIN INJECTION BP
Sterile solution
1 MG/ML
(10mg, 50mg, 100mg cisplatin per vial)
THERAPEUTIC CLASSIFICATION
Antineoplastic Agent
Sandoz Canada Inc.
Date of Revision: September 29, 2020
110 Rue de Lauzon
Boucherville, QC
J4B 1E6
Submission Control No: 240523
________________________________________________________________________
_Cisplatin Injection BP_
_Page 2 of 21 _
PRODUCT MONOGRAPH
PR
CISPLATIN INJECTION BP
Sterile solution
1MG/ML
THERAPEUTIC CLASSIFICATION
Antineoplastic Agent
CAUTION
CISPLATIN INJECTION BP IS A POTENT DRUG AND SHOULD BE USED
ONLY BY PHYSICIANS EXPERIENCED WITH CANCER
CHEMOTHERAPEUTIC DRUGS (SEE WARNINGS AND PRECAUTIONS).
BLOOD COUNTS AS WELL AS RENAL AND HEPATIC FUNCTION TESTS
SHOULD BE TAKEN REGULARLY. DISCONTINUE THE DRUG IF
ABNORMAL DEPRESSION OF BONE MARROW OR ABNORMAL RENAL OR
HEPATIC FUNCTION IS SEEN.
ACTION AND CLINICAL PHARMACOLOGY
Cisplatin has biochemical properties similar to those of bifunctional
alkylating agents
producing inter-strand and intra-strand cross-links in DNA. It is
apparently not cell-cycle
specific.
PHARMACOKINETICS
Following bolus injection, or intravenous infusion over 2 to 7 hours,
of doses ranging
from 50 to 100 mg/m
2
, plasma cisplatin half-life is approximately 30 minutes. The ratios
of cisplatin to total, free (ultrafilterable) platinum in the plasma
range from 0.4 to 1.1
after a dose of 100 mg/m
2
.
Cisplatin does not undergo instantaneous and reversible binding to
plasma proteins
characteristic of normal drug-protein binding. However, the platinum
from cisplatin
becomes bound to plasma proteins. These complexes are slowly
eliminated with a half-
life of 5 days or more.
Following cisplatin doses of 20 to 120 mg/m
2
, the concentrations of platinum are highest
in liver, prostate and kidney, somewhat lower in bladder, muscle,
testicle, pancreas and
spleen and lowest in bowel, adrenal, heart, lung, cerebrum and
cerebellum. Platinum is
present in tissues for as long as 180 days after the last
administration. With the exception
____
                                
                                اقرأ الوثيقة كاملة
                                
                            

مستندات بلغات أخرى

خصائص المنتج خصائص المنتج الفرنسية 29-09-2020

تنبيهات البحث المتعلقة بهذا المنتج

عرض محفوظات المستندات